Bisphosphonates are a class of drugs extremely important in the treatment of several pathologies such as bony metastases, malignant hypercalcaemia, multiple myeloma, osteoporosis, and Paget's disease. Since necrosis in the maxilla and jaw area is often associated to treatment with Bisphosphonates, the present study wants to assess any possible relation between Bisphosphonates therapy and osteonecrosis. Here, we report on a patient affected by multiple myeloma (MM) who developed necrosis of the maxilla and exposure of the zygomatic bone during bisphosphonates therapy (BT). In literature, to our knowledge no cases with so huge extension of necrosis have been reported to date. He refused any surgical treatment. After a 5-year follow-up, the disease is now well controlled without progression, with long term or intermittent courses of penicillin-type antibiotics. Bisphosphonates, such as pamidronate and zoledronate, play a determinant role in the treatment of several oncological diseases. Nevertheless, they could pose a risk for osteonecrosis in the maxilla and jaw region. Furthermore, the treatment of bisphosphonates-related osteonecrosis is still a challenge due to the extreme aggressiveness of the syndrome. Hence, the conservative or the aggressive approaches have to be carefully considered each time, case by case.

Osteonecrosis of the maxilla with zygomatic bone exposure by zolendronic acid: A case report

IACONETTA, GIORGIO
2014-01-01

Abstract

Bisphosphonates are a class of drugs extremely important in the treatment of several pathologies such as bony metastases, malignant hypercalcaemia, multiple myeloma, osteoporosis, and Paget's disease. Since necrosis in the maxilla and jaw area is often associated to treatment with Bisphosphonates, the present study wants to assess any possible relation between Bisphosphonates therapy and osteonecrosis. Here, we report on a patient affected by multiple myeloma (MM) who developed necrosis of the maxilla and exposure of the zygomatic bone during bisphosphonates therapy (BT). In literature, to our knowledge no cases with so huge extension of necrosis have been reported to date. He refused any surgical treatment. After a 5-year follow-up, the disease is now well controlled without progression, with long term or intermittent courses of penicillin-type antibiotics. Bisphosphonates, such as pamidronate and zoledronate, play a determinant role in the treatment of several oncological diseases. Nevertheless, they could pose a risk for osteonecrosis in the maxilla and jaw region. Furthermore, the treatment of bisphosphonates-related osteonecrosis is still a challenge due to the extreme aggressiveness of the syndrome. Hence, the conservative or the aggressive approaches have to be carefully considered each time, case by case.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11386/4582072
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact